相关实验视频
Updated: Sep 11, 2025

06:59
Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
38.3K
在化疗后的早期乳腺癌中加速动脉样硬化
Kyle Varkoly1, Ali Khan2, Muhammad Ahmad1
1Department of Cardiovascular Medicine, McLaren Flint, Flint, Michigan, USA; (b)Department of Interventional Cardiology, McLaren Flint, Flint, Michigan, USA.
JACC. Case reports
|August 15, 2025
概括
甲基化疗可以在癌症患者中导致过早的动脉样硬化心血管疾病 (ASCVD). 对于这些幸存者来说,需要新的查指南来改善心血管健康.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 预防医学 预防医学
背景情况:
- 目前的动脉样硬化心血管疾病 (ASCVD) 查指南缺乏针对接受动脉样硬化心血管疾病化疗的癌症患者的具体建议.
- 医生的偏好和症状驱动的评估往往在这个人群中决定ASCVD查.
相关概念视频
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Atherosclerosis IV: Nursing Management
50
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
50
Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
Atherosclerosis I: Introduction
82
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
82

